Skip to main content

April 2010

 

Clinical courses

Franco-Indian looking for a dynamic professional to be a part of this high performing team as a: MARKETING MANAGER

Franco-Indian Pharmaceuticals Pvt. Ltd., a name that stands for quality and innovation, is one of the major players in the Pharmaceutical Industry in India.
Our innovative, value added products improve the quality of life of people and ease their sufferings and help them to enjoy, longer, healthier and more productive lives.
Franco-Indian’s strongest attributes are the unwavering focus on ethics, transparency, corporate culture, quality of products, contribution to society and commitment to growth.

ICRI ties up with South Carolina Medical University to offer masters in Health Administration-Global

After the approval of the Foreign Universities Bill by the government, ICRI, the pioneers in healthcare and clinical research education, has entered into an academic/strategic alliance with Medical University of South Carolina (MUSC) to offer Masters in Health Administration-Global. Eminent faculty and administrative staff of MUSC were present during the launch.

GSK gets clean chit from DCGI for running cervical cancer vaccine ads in media

The multinational drug company GlaxoSmithKline (GSK), which had run an advertisement blitzkrieg in several national newspapers in the country on cervical cancer vaccine late last year in gross violation of Drugs and Cosmetics Act, 1940 and Drugs and Magical Remedies Act 1954, has been completely absolved of any irregularities by the drug controller general of India (DCGI) Dr Surinder Singh, it is learnt.

Deep Brain Stimulation Improves Quality of Life in Advanced Parkinson's

In a randomized, multicenter study of advanced Parkinson's disease (PD) patients, those treated with deep brain stimulation (DBS) of the subthalamic nucleus combined with best medical therapy had better self-reported quality of life at 1 year than those treated with best medical therapy alone.

Long-Term Use of Anabolic Steroids Associated With Reduced LV Ejection Fraction

April 29, 2010 (Boston, Massachusetts) — Long-term users of anabolic androgenic steroids have a high risk of developing cardiac dysfunction, which may be severe enough to increase the risk of heart failure, a new study suggests [1].

The study, published online April 27, 2010 in Circulation: Heart Failure, was conducted by a group led by Dr Aaron Baggish (Massachusetts General Hospital, Boston, MA).

India participates in ICGC with oral cancer as site for research

India is participating in International Cancer Genome Consortium (ICGC) with oral cancer as the site for research. In view of its high prevalence in India and the existence of possible interacting environmental factors, India will focus on oral cancer as a part of the ICGC activities. In particular, India will be focusing on the gingivo-buccal cancer.

PCI warns pharmacy colleges planning to launch 2nd shift for B Pharm

The Pharmacy Council of India (PCI), the statutory body governing the pharmacy education in the country, has warned against the move by some of the institutes to start a second shift for pharmacy courses. PCI said that it would not approve such courses or students taking such courses as per the Pharmacy Act, 1948.

Cytomegalovirus Resistance Linked to Subtherapeutic Ganciclovir

The resistance of cytomegalovirus (CMV) to ganciclovir prophylaxis might be related to subtherapeutic levels of the antiviral agent, according to investigators from Loyola University Medical Center in Maywood, Illinois.

Although the study was small, the findings sparked a lively discussion among those attending the session on transplant infections at the International Society for Heart & Lung Transplantation 30th Anniversary Meeting.

HPV Testing May Detect More Precancerous Cells Than Conventional Cytology

As part of a well-established organized screening program, primary human papillomavirus (HPV) screening with cytology triage is more sensitive than conventional cytology in the detection of cervical intraepithelial neoplasia (CIN) grade III, according to the results of a randomized trial reported online April 28 in the BMJ.